| XLS |
EUR million |
Jan.–June 2010 |
Jan.–June 2009 |
Profit after tax |
381.5 |
170.1 |
Depreciation/amortization and impairment losses (non-current assets) |
481.2 |
443.4 |
Changes in inventories |
–36.6 |
–27.6 |
Changes in trade accounts receivable |
–230.0 |
–65.3 |
Changes in trade accounts payable |
28.3 |
–30.5 |
Changes in provisions |
51.9 |
77.7 |
Changes in other assets and liabilities |
77.0 |
–88.5 |
Neutralization of gain/loss on disposals of assets |
–1.0 |
–2.0 |
Other non-cash income and expenses |
–7.2 |
–2.3 |
Net cash flows from operating activities |
744.9 |
475.0 |
|
|
|
Purchase of intangible assets |
–31.0 |
–45.3 |
Purchase of property, plant and equipment |
–155.9 |
–189.7 |
Acquisitions and investments of non-current financial assets |
–21.4 |
–8.5 |
Disposal of non-current assets |
15.0 |
11.5 |
Purchase/sale of marketable securities |
–0.5 |
0.1 |
Changes in financial assets covering pensions |
–4.6 |
0.0 |
Changes in other financial investments |
1,355.4 |
–1,034.8 |
Net cash flows from investing activities |
1,157.0 |
–1,266.6 |
|
|
|
Dividend payments |
–71.6 |
–104.5 |
Profit transfers to E. Merck KG and changes in reserves |
–109.6 |
31.8 |
Changes in liabilities to related parties |
–58.1 |
–188.5 |
Bonds issued |
3,181.7 |
746.0 |
Changes in current and non-current financial liabilities |
268.4 |
28.8 |
Net cash flows from financing activities |
3,210.8 |
513.6 |
|
|
|
Changes in cash and cash equivalents |
5,112.8 |
–278.0 |
Changes in cash and cash equivalents due to currency translation |
17.6 |
1.0 |
Cash and cash equivalents as of January 1 |
541.4 |
692.7 |
Cash and cash equivalents as of June 30 |
5,671.8 |
415.7 |
back
